2024 Speaker Faculty:

Zdravka Medarova

Founder & Chief Scientific Officer

TransCode Therapeutics

Alpana Kumari

Manager, Biopharma Business Development

Bio-Techne

Wayne Doyle

Senior Bioinformatics Scientist

Eclipsebio

Soren Ottosen

VP Research

Sixfold Bioscience Inc

Ken Yamada

Assistant Professor

University of Massachusetts Medical School

Jay Kim

Chief Executive Officer

K2B Therapeutics

Marie Wikstrom Lindholm

Chief Scientific Officer

Silence Therapeutics

GLENN KAZO

CBO

ARIZ

Shanthi Ganesh

Director - Discovery Research

Dicerna Pharmaceuticals, Inc.

Jim Weterings

Vice President Research, RNA Therapeutics & Delivery

Sirnaomics Inc.

James ferguson

Chief Medical Officer,

Matinas BioPharma

Mano Manoharan

Senior Vice President - Innovation Chemistry & Alnylam Distinguished Scientist

Alnylam Pharmaceuticals

Ying Yu

Associate Director

AbbVie

Frank Slack

Professor

Beth Israel Deaconess Medical Center, Harvard Medical School

Guy Hermans

CEO

Sapreme Technologies

Iris Grossman

Chief Therapeutics Officer

Eleven Therapeutics

Zhanna Druzina

Senior Director

Aro Biotherapeutics

Richard Welch

Vice President - Chemistry, Manufacturing & Controls

Sirnaomics Inc.

Debasis Patra

Vice President, Senior Director & Head Of Chemistry, Manufacturing & Controls

OliX Pharmaceuticals

Benjamin Winkeljann

Group Leader

RNhale GmbH & LMU Munich

Anja H?g

Entrepreneur in Residence

BioInnovation Institute

Pooja Dua

Director, Research & Development Head

OliX US

Qian Chen

Scientific Director

NanoDe Therapeutics